John Mariadason

22PUBLICATIONS
139CO-AUTHORS
Models of care and place of birthEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 03, 2026
Pregnancy-induced tissue-resident memory-like T cells contribute to tumor control in breast cancer.

|Jun 17, 2026
Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis.

|Apr 24, 2026
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

|Jun 05, 2025
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.

Ian Y Luk, Jennifer K Mooi, Dmitri Mouradov

|May 25, 2024
Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer.

David K Lau, Jack P Collin, John M Mariadason

|Mar 01, 2024
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer.

Laura J Jenkins, Ian Y Luk, Fiona Chionh

Pageof 4

Frequent Collaborators

6 joint publications

Walter D Fairlie

4 joint publications

Camilla M Reehorst

4 joint publications

Matthias Ernst

3 joint publications

Erinna F Lee